Background: The aim of this study was to evaluate early and 5-year outcomes of endovascular aneurysm repair (EVAR) with Zenith Alpha Abdominal in the context of a multicenter regional retrospective registry comparing patients with hostile and nonhostile aortic necks. Methods: A retrospectively maintained dataset identified all consecutive patients with Abdominal Aortic Aneurysms underwent elective EVAR with implantation of a Zenith Alpha Abdominal in 7 centers between January 2016 and December 2022. Two-hundred-twenty-eight patients have been included in the present study: 98 (43%) with a hostile neck (Group HN ), and 130 (57%) with a no-hostile neck (Group n-HN ). Early (30-day) outcomes in terms of technical and clinical successes were assessed and compared. Estimated 5-year outcomes were evaluated and compared in terms of survival, freedom from type I/III endoleak, freedom from surgical conversion, freedom from limb graft occlusion, and freedom from any device-related reintervention(s) by using life-table analysis (Kaplan-Meier curves) and log-rank test. Results: Female gender was more frequent in Group HN (15.3% vs. 5.3%, P - 0.01). Thirty-day technical success rate was 96.9% in Group HN, and 100% in Group n-HN (P - 0.08), while 30day clinical success rate was 96.9% in Group HN, and 99.2% in Group n-HN (P - 0.21). Overall median follow-up period was 32.1 months [InterQuartile Range 14-47]. Estimated 5-year survival rates were comparable (67.1% in Group HN, and 77.9% in Group n-HN, P - 0.47). During the follow-up no endoleak type III have been detected in both groups. At 5 years there were no differences between the two groups in terms of freedom from surgical conversion (95.1% Group HN vs. 96.7% Group n-HN; P - 0.71, log-rank 0.14), freedom from limb graft occlusion (95.7% Group HN vs. 93.5% Group n-HN; P - 0.58, log-rank 0.29), and freedom from any device-related reintervention(s) (70.5% Group HN vs. 89.7% Group n-HN; P - 0.19, log-rank 1.72). Starting from the third year of follow-up, hostile neck affected type I endoleak rate (70.2% Group HN vs. 98.4% Group nHN; P - 0.008, log-rank 6.96). Female gender was the only factor affecting type I endoleak onset Conclusion: In the present multicenter experience hostile neck was more frequent in female inal implantation starting from the third year of follow-up from the index procedure.

Endovascular Aneurysm Repair with Zenith Alpha Abdominal Stent-Graft in Hostile and nonhostile Aortic Neck Anatomies

Giulia Bertagna
Primo
Writing – Original Draft Preparation
;
Nicola Troisi
Writing – Original Draft Preparation
;
Sofia Pierozzi
Membro del Collaboration Group
;
Valerio Artini
Membro del Collaboration Group
;
Raffaella Berchiolli
Ultimo
Writing – Original Draft Preparation
2025-01-01

Abstract

Background: The aim of this study was to evaluate early and 5-year outcomes of endovascular aneurysm repair (EVAR) with Zenith Alpha Abdominal in the context of a multicenter regional retrospective registry comparing patients with hostile and nonhostile aortic necks. Methods: A retrospectively maintained dataset identified all consecutive patients with Abdominal Aortic Aneurysms underwent elective EVAR with implantation of a Zenith Alpha Abdominal in 7 centers between January 2016 and December 2022. Two-hundred-twenty-eight patients have been included in the present study: 98 (43%) with a hostile neck (Group HN ), and 130 (57%) with a no-hostile neck (Group n-HN ). Early (30-day) outcomes in terms of technical and clinical successes were assessed and compared. Estimated 5-year outcomes were evaluated and compared in terms of survival, freedom from type I/III endoleak, freedom from surgical conversion, freedom from limb graft occlusion, and freedom from any device-related reintervention(s) by using life-table analysis (Kaplan-Meier curves) and log-rank test. Results: Female gender was more frequent in Group HN (15.3% vs. 5.3%, P - 0.01). Thirty-day technical success rate was 96.9% in Group HN, and 100% in Group n-HN (P - 0.08), while 30day clinical success rate was 96.9% in Group HN, and 99.2% in Group n-HN (P - 0.21). Overall median follow-up period was 32.1 months [InterQuartile Range 14-47]. Estimated 5-year survival rates were comparable (67.1% in Group HN, and 77.9% in Group n-HN, P - 0.47). During the follow-up no endoleak type III have been detected in both groups. At 5 years there were no differences between the two groups in terms of freedom from surgical conversion (95.1% Group HN vs. 96.7% Group n-HN; P - 0.71, log-rank 0.14), freedom from limb graft occlusion (95.7% Group HN vs. 93.5% Group n-HN; P - 0.58, log-rank 0.29), and freedom from any device-related reintervention(s) (70.5% Group HN vs. 89.7% Group n-HN; P - 0.19, log-rank 1.72). Starting from the third year of follow-up, hostile neck affected type I endoleak rate (70.2% Group HN vs. 98.4% Group nHN; P - 0.008, log-rank 6.96). Female gender was the only factor affecting type I endoleak onset Conclusion: In the present multicenter experience hostile neck was more frequent in female inal implantation starting from the third year of follow-up from the index procedure.
2025
Bertagna, Giulia; Troisi, Nicola; Pulli, Raffaele; De Donato, Gianmarco; Pierozzi, Sofia; Artini, Valerio; Berchiolli, Raffaella
File in questo prodotto:
File Dimensione Formato  
Hostile neck 2025.pdf

non disponibili

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - accesso privato/ristretto
Dimensione 1 MB
Formato Adobe PDF
1 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1312428
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact